title: Selective antioxidant enzymes during ischemia/reperfusion in myocardial infarction.
abstract: The study of ischemia/reperfusion injury included 25 patients in the acute phase of myocardial infarction (19 perfused, 6 remained non-reperfused as evaluated according to the time course of creatine kinase and CK-MB isoenzyme activity) and a control group (21 blood donors). Plasma level of malondialdehyde was followed as a marker of oxidative stress. Shortly after reperfusion (within 90 min), a transient increase of malondialdehyde concentration was detected. The return to the baseline level was achieved 6 h after the onset of therapy. The activity of a free radical scavenger enzyme, plasma glutathione peroxidase (GPx), reached its maximum 90 min after the onset of treatment and returned to the initial value after 18 h. The specificity of the GPx response was confirmed by comparing with both non-reperfused patients and the control group, where no significant increase was detected. The erythrocyte Cu,Zn-superoxide dismutase (SOD) did not exhibit significant changes during the interval studied in perfused patients, probably due to the stability of erythrocyte metabolism. In non-reperfused patients, a decrease of SOD was found during prolonged hypoxia. These results help to elucidate the mechanisms of fast activation of plasma antioxidant system during the reperfusion after myocardial infarction.
authors.affiliation: Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Czech Republic.
authors.forename: V
authors.initials: V
authors.lastname: Muzáková
authors.forename: R
authors.initials: R
authors.lastname: Kandár
authors.forename: P
authors.initials: P
authors.lastname: Vojtísek
authors.forename: J
authors.initials: J
authors.lastname: Skalický
authors.forename: Z
authors.initials: Z
authors.lastname: Cervinková
mesh_terms: D000368:Aged; D000975:Antioxidants / Q000378:metabolism*; D003402:Creatine Kinase / Q000097:blood; D052279:Creatine Kinase, MB Form; D004912:Erythrocytes / Q000201:enzymology; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D005609:Free Radicals / Q000378:metabolism; D005979:Glutathione Peroxidase / Q000378:metabolism*; D006801:Humans; D007527:Isoenzymes / Q000097:blood; D008297:Male; D008315:Malondialdehyde / Q000097:blood; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy / Q000378:metabolism*; D015428:Myocardial Reperfusion Injury / Q000378:metabolism*; D013300:Streptokinase / Q000008:administration & dosage; D013482:Superoxide Dismutase / Q000378:metabolism*; D015912:Thrombolytic Therapy
chemical_list: D000975:Antioxidants; D005343:Fibrinolytic Agents; D005609:Free Radicals; D007527:Isoenzymes; D008315:Malondialdehyde; D005979:Glutathione Peroxidase; D013482:Superoxide Dismutase; D003402:Creatine Kinase; D052279:Creatine Kinase, MB Form; D013300:Streptokinase